cancer therapeutic

UTSW Spinout InterAct Therapeutics Selected by Cell & Gene Therapy Incubator Program

by | Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
MORE
OncoNano Taps Veteran Biopharmaceutical Leader as Its New Chief Operating Officer
by | Nov 20, 2025
With more than two decades of experience in product development, strategic operations, and commercial execution across the biotechnology industry, Brent Sorrells will help drive OncoNano’s next phase of growth and operational excellence, the company said.
MORE